Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter

3 years ago

Shockwave L⁶ Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral VesselsSANTA CLARA, Calif., March 14, 2023 (GLOBE…

Novan Announces $6.0 Million Registered Direct Offering

3 years ago

DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it…

EMulate Therapeutics Announces the Addition of Donna Morgan Murray, Ph.D., to its Board of Directors

3 years ago

BELLEVUE, Wash., March 14, 2023 (GLOBE NEWSWIRE) -- EMulate Therapeutics, Inc. (“EMulate” or the “Company”) a clinical-stage company, developing digital…

LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover

3 years ago

BOUCHERVILLE, Quebec, March 14, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma Group Inc. (the…

MedAvail Announces Closing of $16 Million Private Placement

3 years ago

PHOENIX, March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced…

H1 Launches Advanced Diversity Insights and Clinical Trial Performance Insights

3 years ago

First to offer diversity insights, healthcare data leader H1 expands its offering with two new capabilities focused on supporting diversity…

ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual Meeting

3 years ago

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 13, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology…

Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board

3 years ago

Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization…

Shiru launches OleoPro™, a protein-based alternative fat ingredient to unlock the next generation of plant-based foods

3 years ago

Shiru's first commercial product, OleoPro™, delivers a 90% saturated fat reduction and improved taste performance compared to current fat solutions…

First Use of the Galaxy System™ in Human Patients Conducted at Macquarie University Hospital in Australia

3 years ago

Next generation, integrated solution for navigated robotic bronchoscopy is now FDA clearedSAN CARLOS, Calif., March 13, 2023 (GLOBE NEWSWIRE) --…